This is a demo store. No orders will be fulfilled.

Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

Technological Advances Enabling Stem Cells Reprogramming

Technological Advances Enabling Stem Cells Reprogramming

Technologies Paving New Avenues to Drive Breakthrough Research Toward the Discovery of Next Generation Therapeutics

RELEASE DATE
30-Apr-2019
REGION
Global
Research Code: D89C-01-00-00-00
SKU: HC03169-GL-TR_23095
$4,950.00
In stock
SKU
HC03169-GL-TR_23095
$4,950.00
DownloadLink
Add to Compare

Pay by invoice

ENQUIRE NOW

Description

Since the advent of stem cells reprogramming after the discovery of the differentiation factors that allow the creation of human induced pluripotent stem cells, researchers all around the world are strongly committed to develop novel methods to design and build human stem cells.

Indeed, there is an increasing demand for the more efficient production systems and manufacturing methods of stem cells for potential investigation in disease management. This trend is emphatically envisaged to accelerate the development of both regenerative medicine and drug discovery and development.

Moreover, stem cell therapies are acclaimed as the next major advancements in transforming healthcare. Pharmaceutical companies are heavily investing in expanding their cellular therapy portfolio based on stem cells reprogramming, thereby exhibiting a strong evidence of the understanding future of stem cells reprogramming in the treatment of a broad spectrum of life-threatening diseases.

Table of Contents

1.1 Stem Cells Reprogramming: The Bigger Picture

1.2 Stem Cells Reprogramming: A Promising Revolution

1.3 Research Focus: Stem Cells Reprogramming

1.4 Research Focus: Stem Cells Reprogramming

1.5 Research Scope: Unveiling a Radically Novel Technology

1.6 Analysis Framework: Frost & Sullivan’s Core Value

1.7 Research Methodology: Five Steps toward Success

2.1 Key Elements of Analysis: Stem Cells Reprogramming

2.2 Brief Overview of Stem Cells Reprogramming

2.3 Evolving Stem Cells Reprogramming

2.4 Delivery Methods of Pluripotency Induction

2.5 Molecular Methods of Pluripotency Induction

3.1 Stem Cells Reprogramming Innovations

3.2 Stem Cells Reprogramming Developments

3.3 Stem Cells Reprogramming Advances

3.4 Stem Cells Reprogramming Technologies

3.5 Stem Cells Reprogramming Breakthroughs

3.6 Stem Cells Reprogramming Disruption

3.7 Stem Cells Reprogramming Approaches

3.8 Stem Cells Reprogramming Platforms

3.9 Stem Cells Reprogramming Novelties

3.10 Stem Cells Reprogramming Innovations

4.1 Market Dynamics and Business Opportunities

4.2 Market Forecast by Application

4.3 Market Forecast by Source

4.4 Market Forecast by Sector

4.5 Market Forecast by Technology

4.6 Market Forecast by Region

5.1 Technology Synergy Reshaping the Value Chain

5.2 New Approaches Driving Solutions

5.3 Business Model Hybridization

5.4 Technology and Business Landscape: Accelerators

5.5 Technology and Business Landscape: Challenges

5.6 Technology Transfer Assessment and Perceptions

5.7 Principal Innovators and Patent Holders

6.1 Funding and Investment Models and Adoption

6.2 Funding Trends and Contribution Focus

6.3 Principal Funding Sources

6.4 Funded Programs by Region

6.5 Most Granted Institutions

7.1 Roadmap Tapping into Technology Synergy

7.2 Multicriteria Approach for Benchmarking

7.3 Strategic Portfolio Assessment

7.4 Level 1 Criteria: Innovation Development

7.5 Level 1 Criteria: Financial Performance

7.6 Level 1 Criteria: Market Evolution

7.7 Level 2 Criteria: Key Actions for Success

7.8 Analytic Performance Results

7.9 Multicriteria Final Assessment

7.10 Future Perspective for Stem Cells Reprogramming

8.1 Technology Platforms to Watch

8.2 Strategic Business Cases

8.3 Strategic Business Developments

8.4 Critical Success Factors

9.1 Key Industry Influencers

9.2 Key Industry Models

9.3 Key Industry Participants

9.4 Key Industry References

9.5 Key Industry Exemplars

Legal Disclaimer

Request Sample
Popular Topics

polyamides market

offshore market

artificial lift market

video analytics market

smart lighting market

augmented reality market

energy storage market

neurology market

nutritional supplement market

polyamide market

Since the advent of stem cells reprogramming after the discovery of the differentiation factors that allow the creation of human induced pluripotent stem cells, researchers all around the world are strongly committed to develop novel methods to design and build human stem cells. Indeed, there is an increasing demand for the more efficient production systems and manufacturing methods of stem cells for potential investigation in disease management. This trend is emphatically envisaged to accelerate the development of both regenerative medicine and drug discovery and development. Moreover, stem cell therapies are acclaimed as the next major advancements in transforming healthcare. Pharmaceutical companies are heavily investing in expanding their cellular therapy portfolio based on stem cells reprogramming, thereby exhibiting a strong evidence of the understanding future of stem cells reprogramming in the treatment of a broad spectrum of life-threatening diseases.
More Information
No Index No
Podcast No
Author Cecilia Van Cauwenberghe
Industries Healthcare
WIP Number D89C-01-00-00-00
Is Prebook No